Franklin G Miller

Ethical Challenges of Human Research

Selected Essays

• Gebundenes Buch

Produktbeschreibung

This book contains 22 essays on the ethics of research involving human subjects written over a 15-year period. Topics addressed include the ethics of clinical trials, controversial study designs, and informed consent.

---

Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.

Produktdetails

• Verlag: Sinauer Associates Is an Imprint of Oxford University Press
• Seitenzahl: 352
• Erscheinungstermin: 23. Oktober 2012
• Englisch
• Abmessung: 241mm x 161mm x 30mm
• Gewicht: 588g
• ISBN-13: 9780199896202
• ISBN-10: 0199896208
• Artikelnr.: 35563274

Autorenporträt

Department of Bioethics, National Institutes of Health. Co-editor of The Oxford textbook of Clinical Research Ethics, and The Ethics of Consent

Inhaltsangabe

* Preface
* Acknowledgments
* Part One: Protecting Human Subjects in Clinical Research: A General
Perspective
* 1. Miller FG. Situating research ethics: revisiting Beecher and Jonas
* 2. Miller FG, Wertheimer A. Facing up to paternalism in research
ethics. Hastings Center Report 2007;37(3):24-34.
* 3. Miller FG, Joffe S. Limits to research risks. Journal of Medical
Ethics 2009;35:445-449.
* Part Two: Study Design
* 4. Miller FG, Rosenstein DL. Psychiatric symptom-provoking studies:
an ethical appraisal. Biological Psychiatry. 1997;42:403-9.
* 5. Miller FG, Grady C. The ethical challenge of infection-inducing
challenge experiments. Clinical Infectious Diseases. 2001;33:1028-33.
* 6. Miller FG. Placebo-controlled trials in psychiatric research: an
ethical perspective. Biological Psychiatry. 2000;47:707-16.
* 7. Miller FG, Brody H. What makes placebo-controlled trials
unethical? The American Journal of Bioethics. 2002;2(2):3-9.
* 8. Miller FG, Emanuel EJ, Rosenstein DL, Straus SE. Ethical issues
concerning research on complementary and alternative medicine. JAMA
2004;291:599-604.
* 9. Miller FG. Sham surgery: an ethical analysis. American Journal of
Bioethics 2003;3(4):41-8;
* 10. Miller FG, Joffe S. Benefit in phase 1 oncology trials:
therapeutic misconception or reasonable treatment option? Clinical
Trials 2008;5:617-23.
* 11. Miller FG, Wendler D, Swartzman L. Deception in research on the
placebo effect. PLoS Medicine 2005;2(9):e262.
* 12. Miller FG, Gluck JP, Wendler D. Debriefing and accountability in
deceptive research. Kennedy Institute of Ethics Journal
2008;18:235-51.
* Part Three: Therapeutic Orientation and Equipoise
* 13. Miller FG, Rosenstein DL, DeRenzo EG. Professional integrity in
clinical research. Journal of the American Medical Association.
1998;280:1449-54.
* 14. Miller FG, Rosenstein DL. The therapeutic orientation to clinical
trials. New England Journal of Medicine. 2003;348:1383-86.
* 15. Miller FG, Brody H. A critique of clinical equipoise: Therapeutic
misconception in the ethics of clinical trials. Hastings Center
Report. 2003;33(3):19-28.
* 16. Miller FG, Brody H. Clinical equipoise and the incoherence of
research ethics. Journal
* of Medicine and Philosophy 2007;32:151-65.
* 17. Miller FG, Joffe S. Equipoise and the randomized clinical trial
dilemma. New England Journal of Medicine 2011;364:476-80.
* Part Four: Consent
* 18. Miller FG, Joffe S. Evaluating the therapeutic misconception.
Kennedy Institute of Ethics Journal 2006;16:353-66.
* 19. Miller FG, Wendler D. Is it ethical to keep interim findings of
randomized controlled trials confidential? Journal of Medical Ethics
2008;34:198-201.
* 20. Miller FG. Research on medical records without informed consent,
Journal of Law, Medicine and Ethics 2008;36:560-66.
* 21. Miller FG, Pearson SD. Coverage with evidence development:
ethical issues and policy implications. Medical Care 2008;46:746-57.
* 22. Miller FG, Wertheimer A. The fair transaction model of informed
consent: an alternative to autonomous authorization, Kennedy
Institute of Ethics Journal 2011;21:201-18.